ARCHIVES

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

This article is from The Cancer Letter archive.

Vol. 40 No. 37 | October 3, 2014

Download PDF Visit The Full Archive

Related Articles

Feds Should Lead Quality Improvement In Government Health Programs, IOM Report Says

November 8, 2002

AACR Presents 2014 Awards, Arteaga Becomes President at Annual Meeting

April 11, 2014

Fisher, NSABP Executive Committee, File Injunction Seeking Herberman’s Removal

August 12, 1994

Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial

October 31, 2014

Letter: A Modest Proposal To Abolish FDA

January 26, 1996

In Brief: Commerce Dept. Open Radiation Standards Facility For Mammography Calibration

April 4, 1996